Please login to the form below

Not currently logged in
Email:
Password:

Flu vaccine subsidy for Takeda

Takeda Pharmaceutical is to receive a 23.9bn Yen subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines

Takeda Pharmaceutical is to receive a 23.9bn Yen (€215m) subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines.

The company's current influenza-related projects include an agreement with Baxter International to develop the proprietary Vero cell culture-based influenza vaccine technology.

Takeda has already introduced the technology into its experimental production facilities Hikari City having received a similar subsidy in 2010.

The extra funding will enable Takeda to continue the development work it had commenced and make preparations for full-scale manufacturing, including constructing a commercial production facility at the Hikari plant.

A new drug approval for an influenza vaccine is expected by the end of the financial year 2013, according to Takeda.

23rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics